Andrew W. Harman

1.0k total citations
27 papers, 864 citations indexed

About

Andrew W. Harman is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Andrew W. Harman has authored 27 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 9 papers in Oncology and 6 papers in Hepatology. Recurrent topics in Andrew W. Harman's work include Drug-Induced Hepatotoxicity and Protection (17 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Andrew W. Harman is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (17 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Andrew W. Harman collaborates with scholars based in Australia and United States. Andrew W. Harman's co-authors include Philip Burcham, Gregory M. Adamson, Lawrence J. Fischer, Luana Fischer, Anna‐Liisa Nieminen, Brian Herman, John J. Lemasters, Glenn J. Self, Christine Henry and Brian G. Priestly and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Andrew W. Harman

27 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew W. Harman Australia 15 496 222 211 184 114 27 864
M Hashimoto Japan 11 742 1.5× 191 0.9× 183 0.9× 272 1.5× 94 0.8× 20 1.1k
Yasuhiro Masubuchi Japan 16 598 1.2× 153 0.7× 221 1.0× 242 1.3× 115 1.0× 29 902
Iréne Anundi Sweden 15 267 0.5× 240 1.1× 130 0.6× 92 0.5× 120 1.1× 25 836
Tamara R. Knight United States 10 701 1.4× 301 1.4× 390 1.8× 213 1.2× 192 1.7× 10 1.1k
Kai E. Penttilä Finland 14 346 0.7× 225 1.0× 172 0.8× 148 0.8× 218 1.9× 21 892
C.R. de Castro Argentina 16 488 1.0× 180 0.8× 53 0.3× 174 0.9× 177 1.6× 43 899
E.C. de Ferreyra Argentina 14 479 1.0× 142 0.6× 57 0.3× 166 0.9× 92 0.8× 56 749
O.M. de Fenos Argentina 10 471 0.9× 128 0.6× 54 0.3× 157 0.9× 86 0.8× 33 644
Marlene E. Kyle United States 14 311 0.6× 323 1.5× 97 0.5× 126 0.7× 59 0.5× 17 931
Naoko Hanawa United States 8 679 1.4× 418 1.9× 393 1.9× 197 1.1× 312 2.7× 15 1.2k

Countries citing papers authored by Andrew W. Harman

Since Specialization
Citations

This map shows the geographic impact of Andrew W. Harman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Harman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Harman more than expected).

Fields of papers citing papers by Andrew W. Harman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Harman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Harman. The network helps show where Andrew W. Harman may publish in the future.

Co-authorship network of co-authors of Andrew W. Harman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Harman. A scholar is included among the top collaborators of Andrew W. Harman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Harman. Andrew W. Harman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harman, Andrew W., et al.. (1995). An Evaluation of the Role of Calcium in Cell Injury. The Annual Review of Pharmacology and Toxicology. 35(1). 129–144. 85 indexed citations
2.
Adamson, Gregory M. & Andrew W. Harman. (1993). Oxidative stress in cultured hepatocytes exposed to acetaminophen. Biochemical Pharmacology. 45(11). 2289–2294. 77 indexed citations
3.
Harman, Andrew W., et al.. (1992). Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytes.. Molecular Pharmacology. 41(4). 665–670. 14 indexed citations
4.
Harman, Andrew W., et al.. (1992). Protection from oxidative damage in mouse liver cells. Toxicology Letters. 64-65. 581–587. 15 indexed citations
5.
Harman, Andrew W., Marlene E. Kyle, Ada Serroni, & John L. Farber. (1991). The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophen. Biochemical Pharmacology. 41(8). 1111–1117. 31 indexed citations
6.
Burcham, Philip & Andrew W. Harman. (1991). Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes.. Journal of Biological Chemistry. 266(8). 5049–5054. 187 indexed citations
7.
Adamson, Gregory M., J. M. Papadimitriou, & Andrew W. Harman. (1991). Postnatal Mice Have Low Susceptibility to Paracetamol Toxicity. Pediatric Research. 29(5). 496–499. 13 indexed citations
8.
Harman, Andrew W., et al.. (1990). Postnatal Development of Enzyme Activities Associated with Protection against Oxidative Stress in the Mouse. Neonatology. 57(3-4). 187–193. 13 indexed citations
9.
Harman, Andrew W., Anna‐Liisa Nieminen, John J. Lemasters, & Brian Herman. (1990). Cytosolic free magnesium, ATP, and blebbing during chemical hypoxia in cultured rat hepatocytes. Biochemical and Biophysical Research Communications. 170(2). 477–483. 62 indexed citations
10.
Burcham, Philip & Andrew W. Harman. (1990). Mitochondrial dysfunction in paracetamol hepatotoxicity: In vitro studies in isolated mouse hepatocytes. Toxicology Letters. 50(1). 37–48. 55 indexed citations
11.
Burcham, Philip & Andrew W. Harman. (1989). Paracetamol-induced stimulation of glycogenolysis in isolated mouse hepatocytes is not directly associated with cell death. Biochemical Pharmacology. 38(14). 2357–2362. 13 indexed citations
12.
Burcham, Philip & Andrew W. Harman. (1988). Effect of acetaminophen hepatotoxicity on hepatic mitochondrial and microsomal calcium contents in mice. Toxicology Letters. 44(1-2). 91–99. 20 indexed citations
13.
Adamson, Gregory M. & Andrew W. Harman. (1988). Comparison of the susceptibility of hepatocytes from postnatal and adult mice to hepatotoxins. Biochemical Pharmacology. 37(21). 4183–4190. 8 indexed citations
14.
Harman, Andrew W. & Christine Henry. (1987). Differences in glutathione synthesis and glutathione-S-transferase activities in hepatocytes from postnatal and adult mice. Biochemical Pharmacology. 36(1). 177–179. 10 indexed citations
15.
16.
Fischer, L.J., et al.. (1985). Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice.. Drug Metabolism and Disposition. 13(2). 121–126. 24 indexed citations
17.
Harman, Andrew W. & Lawrence J. Fischer. (1983). Hamster hepatocytes in culture as a model for acetaminophen toxicity: Studies with inhibitors of drug metabolism. Toxicology and Applied Pharmacology. 71(3). 330–341. 27 indexed citations
18.
Fischer, Luana, et al.. (1981). Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 281–286. 52 indexed citations
19.
Harman, Andrew W., D. B. Frewin, & Brian G. Priestly. (1981). Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum.. Occupational and Environmental Medicine. 38(1). 91–97. 12 indexed citations
20.
Harman, Andrew W., Brian G. Priestly, & D. B. Frewin. (1977). A COMPARATIVE STUDY OF ANTIPYRINE PHARMACOKINETICS IN SALIVA AND PLASMA USING A COLOURIMETRIC METHOD OF ANTIPYRINE ANALYSIS. Clinical and Experimental Pharmacology and Physiology. 4(6). 593–596. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Hashimoto Breakdown of academic impact, for papers by Yasuhiro Masubuchi Breakdown of academic impact, for papers by Iréne Anundi Breakdown of academic impact, for papers by Tamara R. Knight Breakdown of academic impact, for papers by Kai E. Penttilä Breakdown of academic impact, for papers by C.R. de Castro Breakdown of academic impact, for papers by E.C. de Ferreyra Breakdown of academic impact, for papers by O.M. de Fenos Breakdown of academic impact, for papers by Marlene E. Kyle Breakdown of academic impact, for papers by Naoko Hanawa
Rankless by CCL
2026